Osarbon® (Osarbon®)

Composition Pharmacodynamics Indications Carefully Contraindications Dosing and Administration Side effects Form release / dosage
Read on
Active substanceAcetarsolAcetarsol
Similar drugsTo uncover
  • Osarbon®
    suppositories the vagina. 
    NIZHFARM, JSC     Russia
    • Dosage form: & nbspVaginal suppositories
    Composition:

    One suppository contains:

    active substance: acetarosol (sarsols) 250 mg;

    Excipients: boric acid - 300 mg; dextrose monohydrate (glucose) - 300 mg; solid fat (Witepsol (grades H 15, W 35), Supposir (marks NA 15, NAS 50)) - until a suppository with a mass of 2.8 g.

    Description:

    Suppositories white or white with a yellowish or kremovatym shade of color, torpedo-shaped.

    Pharmacotherapeutic group:Antiprotozoal agent
    ATX: & nbsp

    G.01.A.B   Arsenic compounds

    Pharmacodynamics:

    Acetarsol, due to the ability to block sulfhydryl enzyme systems, disrupts the metabolic processes of the protozoa (including trichomonads, amoebae), and some spirochetes. To prevent the resorption of the drug (and possible intoxication), it is necessary to maintain the acidic environment of the vagina. Glucose (dextrose), which is part of the drug, is a nutrient substrate for lactobacilli of normal vaginal microflora. Lactobacilli decomposes glucose to form lactic acid, providing an acidic environment of the vagina. Boric acid also supports the acidic environment of the vagina.

    Indications:

    Trichomonas colpitis.

    Contraindications:

    Hypersensitivity to the components of the drug, hepatic and / or renal insufficiency, diabetes mellitus, hemorrhagic diathesis, tuberculosis, pregnancy.

    Dosing and Administration:

    Preliminarily releasing the suppository from the contour cell packaging, it is injected, lying on its back, deep into the vagina. Apply 1 suppository once a day for 10 days.

    Side effects:

    Allergic reactions, hepatitis, polyneuritis.

    Overdose:

    When using the drug Osarbon ® intravaginally, there were no cases of overdose.

    Interaction:

    Drug interaction of the drug has not been described to date.

    Effect on the ability to drive transp. cf. and fur:

    The use of the drug does not affect the management of vehicles and work with machines and equipment.

    Form release / dosage:Vaginal suppositories 250 mg.
    Packaging:

    5 suppositories are placed in a contour mesh package made of a film of polyvinyl chloride laminated polyethylene.

    One or two contour mesh packages, along with instructions for the use of the drug, are placed in a pack of cardboard.

    Storage conditions:

    In the dark place at a temperature of no higher than 25 ° C.

    Keep out of the reach of children.

    Shelf life:3 years. Do not use the product after the expiry date printed on the package.
    Terms of leave from pharmacies:On prescription
    Registration number:P N001062 / 01
    Date of registration:17.08.2007 / 17.06.2016
    Expiration Date:Unlimited
    The owner of the registration certificate:NIZHFARM, JSC NIZHFARM, JSC Russia
    Manufacturer: & nbsp
    Information update date: & nbsp14.06.2017
    Illustrated instructions
      Instructions
      Up